Previous Article | Next Article 
Infection and Immunity, December 2001, p. 7341-7348, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7341-7348.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
CD8+-T-Cell Depletion Ameliorates
Circulatory Shock in Plasmodium berghei-Infected
Mice
Wun-Ling
Chang,1,*
Steven P.
Jones,2
David J.
Lefer,2
Tomas
Welbourne,2
Guang
Sun,3
Lijia
Yin,1
Hodaka
Suzuki,3
Jian
Huang,1
D. Neil
Granger,2,4 and
Henri C.
van der
Heyde3,4,5
Departments of
Medicine,1 Molecular and Cellular
Physiology,2 and Microbiology and
Immunology,3 Inflammation and Immunology
Research Group,4 and Center of
Excellence in Arthritis and Rheumatism,5
Louisiana State University Health Sciences Center, Shreveport,
Louisiana 71130
Received 3 March 2001/Returned for modification 14 May
2001/Accepted 18 July 2001
 |
ABSTRACT |
The Plasmodium berghei-infected mouse model is a
well-recognized model for human cerebral malaria. Mice infected with
P. berghei exhibit (i) metabolic acidosis (pH < 7.3) associated with elevated plasma lactate concentrations, (ii)
significant (P < 0.05) vascular leakage in their
lungs, hearts, kidneys, and brains, (ii) significantly (P < 0.05) higher cell and serum glutamate
concentrations, and (iv) significantly (P < 0.05)
lower mean arterial blood pressures. Because these complications are
similar to those of septic shock, the simplest interpretation of these
findings is that the mice develop shock brought on by the P.
berghei infection. To determine whether the immune system and
specifically CD8+ T cells mediate the key features of shock
during P. berghei malaria, we depleted CD8+
T cells by monoclonal antibody (mAb) treatment and assessed the complications of malarial shock. P. berghei-infected
mice depleted of CD8+ T cells by mAb treatment had
significantly reduced vascular leakage in their hearts, brains, lungs,
and kidneys compared with infected controls treated with rat
immunoglobulin G. CD8-depleted mice were significantly
(P < 0.05) protected from lactic acidosis, glutamate buildup, and diminished HCO3
levels. Although the blood pressure decreased in anti-CD8 mAb-treated mice infected with P. berghei, the cardiac output, as
assessed by echocardiography, was similar to that of uninfected control mice. Collectively, our results indicate that (i) pathogenesis similar
to septic shock occurs during experimental P. berghei malaria, (ii) respiratory distress with lactic acidosis occurs during
P. berghei malaria, and (iii) most components of
circulatory shock are ameliorated by depletion of CD8+ T cells.
 |
INTRODUCTION |
Circulatory shock is defined as an inadequacy of
blood flow in multiple organ systems that leads to inadequate delivery
of nutrients to tissues and inadequate removal of waste products (reviewed in reference 14). The most common causes of
circulatory shock are cardiac and circulatory abnormalities, such as
myocardial infarction, and hemorrhage. Less common but no less deadly
is the development of circulatory shock caused by an infectious agent, also called septic shock (45). Bacteria or bacterial
products in septic shock initiate an inflammatory response that feeds
on itself, becomes uncontrolled, and ultimately destroys the host (45). Leukocytes, including T cells, secrete cytokines
(such as tumor necrosis factor alpha [TNF-
], interleukin 1 [IL-1], and gamma interferon [IFN-
]) that further enhance the
inflammatory response, leading to endothelial dysfunction. The
endothelial dysfunction leads to increased vascular permeability, which
in turn decreases blood volume, diminishes perfusion of tissues, and
results in interstitial edema. In the absence of adequate blood flow,
cells must rely on glycolysis for energy production and consequently
produce lactic acid. While a variety of reflexes and compensatory
mechanisms are activated in response to shock, these efforts to restore
normal tissue perfusion can fail, which leads to a further reduction in
cardiac output, more lactic acidosis, and ultimately tissue necrosis.
Unless this cascade of immune destruction and tissue necrosis is
interrupted, death results.
Malaria is a leading cause of morbidity and mortality. Patients with
severe Plasmodium falciparum malaria develop the following complications: coma or cerebral malaria, respiratory distress with
lactic acidosis, anemia, and occasionally renal failure. The mechanism
of cerebral malaria pathogenesis is being intensely debated, and there
are two major hypotheses, the mechanical hypothesis and the
inflammatory hypothesis (reviewed in references 8 and 31). In the mechanical hypothesis, parasitized red blood
cells bind to the endothelium, causing minithrombi, which in turn lead to the petechial hemorrhaging that is observed on autopsy, tissue hypoxia, and ultimately death. The inflammatory hypothesis states that
the immune response to parasites leads to vascular damage in the brain,
coma, and ultimately death. Clark et al. have proposed that the
inflammatory response leads to breakdown of the blood-brain barrier and
that nitric oxide is a key mediator of pathology
(6). Infection with P. falciparum increases the
levels of inflammatory cytokines (TNF-
, IL-1
, and IFN-
) in
serum. Individuals with a single nucleotide polymorphism in the OCT-1
site of the TNF-
promoter region have a fourfold-greater risk of
developing cerebral malaria and respiratory distress (30).
The inflammatory cytokines are believed to upregulate expression of
several adhesion molecules, such as ICAM-1, VCAM-1, and CD36. CD36 and
ICAM-1 are used by the parasite for cytoadherence to capillary
endothelium (1), but these molecules are also known to be
important for leukocyte endothelial adhesion (43). The
precise pathologic mechanisms in humans are difficult to identify for
obvious ethical reasons.
There are two well-characterized models of cerebral malaria (10,
28, 36, 38). The advantages and disadvantages of these models
have been reviewed elsewhere (8). It has been proposed
that the Plasmodium yoelii model is better than the
Plasmodium berghei model because P. yoelii-parasitized erythrocytes, like P. falciparum-parasitized erythrocytes, bind to brain
microvasculature. However, Hearn et al. reported that P. berghei-parasitized erythrocytes adhere to brain microvasculature,
indicating that both P. yoelii and P. berghei
mimic P. falciparum in this regard (15, 19, 20). We selected the P. berghei model for this study
because P. berghei-infected mice develop impaired
consciousness, whereas P. yoelii-infected mice do not
(10, 28, 38). In the respects pertinent to this study, the
P. berghei-infected mouse model remarkably mimics P. falciparum infection in humans. Virtually all mice with a
susceptible background (C57BL/6 mice) that are infected with P. berghei develop cerebral malaria on day 6 of infection and die
between days 6 and 12, which is the time window for the development of
cerebral malaria (36). In contrast, only 20% of resistant mice (BALB/c and A/J mice) succumb to cerebral malaria. Mice that succumb after day 12 die of hyperparasitemia.
The immune response is vital for pathogenesis of P. berghei
malaria. Elevated levels of inflammatory cytokines are detected in sera
of P. berghei-infected mice, and endothelial cell adhesion molecules are also upregulated (7, 12). If anti-LFA1
monoclonal antibodies (mAbs) are administered or ICAM-1-deficient mice
are used, cerebral malaria does not develop (9, 13).
Petechial hemorrhaging is observed in brains of P. berghei-infected mice, and there is a breakdown of the blood-brain
barrier, as determined by Monastal blue and Evans blue dye
leakage, prior to the onset of cerebral symptoms (33). In
contrast to immunologically intact mice, mice lacking T and B cells or
CD8+ T cells do not develop cerebral malaria,
indicating that the immune response is required for pathogenesis
(11, 16, 44). Type 1 cytokines (IL-2, IFN-
, and
TNF-
) are also required for pathogenesis of experimental cerebral
malaria (7, 27, 44). The role of the immune system in
P. yoelii pathogenesis and the reason for death remain to be
determined. We selected CD8+ T cells to test
whether the immune system contributes to circulatory shock during
malaria because these cells are required for malarial pathogenesis and
depletion is easily verified (44).
Based on the findings described above and similar manifestations in
humans with severe P. falciparum malaria, we hypothesized that P. berghei-infected mice develop complications of
circulatory shock with multiple organ dysfunction and that the immune
response mediates the damage. To test this hypothesis, we first
assessed whether P. berghei-infected mice develop key
features of circulatory shock, including (i) metabolic acidosis, (ii)
increased vascular permeability and tissue edema, (iii) respiratory
distress, and (iv) decreased mean arterial blood pressure. All of these
key features of circulatory shock, which are anticipated in septic shock, were observed in P. berghei-infected mice. To
determine which of these features are immune mediated, we
examined the development of these complications during P. berghei malaria in mice depleted of CD8+ T
cells by mAb treatment. We found that P. berghei-infected
mice depleted of CD8+ T cells were markedly
protected from most of the features of circulatory shock described
above, whereas rat immunoglobulin G (IgG)-treated control mice
developed malarial shock.
 |
MATERIALS AND METHODS |
Parasite, infection, and treatment of mice.
The malarial
parasite used in this study, P. bergehi ANKA, a gift from
William Weidanz, was maintained and used as described previously
(17). This strain kills susceptible C57BL/6 mice on about
day 6 after infection. Frozen parasite stabilate was therefore injected
intraperitoneally (i.p.) into a resistant BALB/c source mouse. Blood
was obtained from the source BALB/c mouse to generate the inoculum used
for the experimental C57BL/6 mice. All experimental mice (both test
mice and control mice) were identically infected, so the use of BALB/c
mice should not have affected the development of malarial pathogenesis.
The experimental mice were injected i.p. with 106
erythrocytes parasitized with P. berghei, and parasitemia
was assessed by examining between 200 and 1,000 erythrocytes in
Giemsa-stained thin blood films.
Female C57BL/6 experimental mice and BALB/c source mice were purchased
from Jackson Laboratories (Bar Harbor, Maine) when they were 4 to 5 weeks old, and they were provided food and water ad libitum. In each
experiment, age- and sex-matched groups consisting of between four and
eight C57BL/6 mice were used, and the animals were between 6 and 12 weeks old. The animals were housed at the Louisiana State University
Health Sciences Center Animal Care Facility, an American Association of
Laboratory Animal Care-approved facility. All procedures were
approved by the Animal Resources Advisory Committee of the Louisiana
State University Health Sciences Center.
To deplete CD8+ T cells, we injected i.p. 1 mg of
anti-CD8 mAb (rat IgG mAb, clone 53-6.72), which is a depleting mAb
(24), on day 1 of P. berghei infection into
mice. Control mice were injected i.p. with 1 mg of rat IgG (Accurate
Scientific). The extent of depletion was assessed on day 4 of infection
by obtaining about 50 µl of blood and analyzing 30 µl of this blood
for the presence of CD3+
CD8+ cells by flow cytometry.
Flow cytometry.
Flow cytometry was performed as described
previously (42). Briefly, erythrocytes from 30 µl of
mouse blood were lysed by hypotonic shock. The cells were washed to
remove erythrocyte debris, and Fc block was added to the cell
suspension to minimize nonspecific binding of mAbs. After 10 min of
incubation, biotinylated anti-CD8 mAb (Pharmingen, San Diego, Calif.)
was added, and the cell suspension was incubated with the antibody for
30 min. After the cells were washed, CD3-fluorescein isothiocyanate,
CD4-phycoerythrin, and streptavidin-allophycocyanin
(Pharmingen) were added to the suspension, and the mixture was
incubated for 30 min. The cells were washed and resuspended in 0.5 ml
of phosphate-buffered saline (PBS), and propidium iodide (Sigma
Chemical Co., St. Louis, Mo.) was added 5 min before data acquisition
in order to exclude dead cells. Flow cytometry data for the cell
suspension were acquired with a FACSCalibur (Becton Dickinson) by using
the CellQuest program and were analyzed by using the Attractors program
(Becton Dickinson).
Assessment of vascular leakage and tissue edema.
Vascular
leakage into selected organs during P. berghei malaria was
assessed as described by Tateishi et al. (39). Briefly, 0.2 ml of 2% Evans Blue dye in saline was injected intravenously into
each mouse. The dye was allowed to circulate for 10 min, and then the
mouse was anesthetized with xylazine (7.5 mg/kg) and ketamine (150 mg/kg) injected i.p. for 6 min. The right atrium was snipped, and then
25 ml of PBS was injected into the left ventricle and 20 ml of PBS was
injected into the right ventricle to remove dye from the vasculature.
Selected organs were removed from the animal, weighed, and placed in a
test tube containing 1 ml of N,N-dimethyl
formamide. The amount of Evans Blue dye in each organ was assessed by
incubating the organ in 1 ml of N,N-dimethyl formamide (Sigma) for 48 h to extract the Evans Blue dye. The A630 of the Evans Blue dye solution
was measured with a spectrophotometer. To ensure that measurements were
in the linear range of the spectrophotometer, the solution was diluted
with N,N-dimethyl formamide until the A630 was less than 0.7. The absorbance
value was divided by the weight of the tissue to normalize for the
amount of tissue. The ratio of wet weight to dry weight was calculated
by dividing the weight of the organ immediately after dissection (wet
weight) by the weight of the organ after it was dried overnight at
80°C.
Lactate, bicarbonate, and amino acid assessment.
To
precipitate proteins, serum samples were promptly treated with an equal
volume of ice-cold 5% trichloroacetic acid, left on ice for 10 min,
and then centrifuged at 10,000 × g for 10 min. Aliquots of the protein-free supernatant containing free amino acids
were then treated with o-phthaladehyde (Fluka, Buchs,
Switzerland) for precolumn derivatization and injected into a
C18 column (4.6 by 250 mm; Microsorb; Varian,
Walnut Creek, Calif.) for separation of the derivatized amino acids.
The column effluent was passed through a fluorescence detector along
with major amino acid standards that formed peaks at the following
retention times: aspartate, 7.85 min; glutamate and glutamine, 16.4 min; homoserine (internal standard), 17.5 min; and alanine, 20.5 min.
The plasma concentrations of the major amino acids were obtained by
dividing the sample peak areas by the peak areas for the corresponding
standards. The coefficients of variation for replicate determinations
of aspartate and glutamate in plasma were 1.6 and 2.3%, respectively (n = 3), and for whole blood the coefficients of
variation were 2.8 and 5.2%, respectively; the levels of recovery of
the glutamate and aspartate standards (100 nmol) added to plasma were
103% ± 4% and 106% ± 5%, respectively.
The plasma lactate concentration was determined enzymatically with
protein-free trichloroacetic acid extracts by using lactate dehydrogenase-catalyzed oxidation of lactate to pyruvate coupled to
NADH formation from NAD monitored spectrophotometrically at 340 nm
(Sigma); the concentration of lactate was calculated by dividing the
absorbance by the absorbance for the lactate standard (4.4 mM). The
coefficient of variation for replicate determinations of control plasma
lactate concentrations was 3% (n = 5). The plasma bicarbonate concentration was measured by determining the total CO2 content manometrically with a microgasometer
(32); under the conditions used the serum bicarbonate
represented virtually all of the CO2.
Echocardiographic assessment of cardiac output.
Mean
arterial blood pressure was determined in anesthetized mice (mice given
sodium pentobarbital [50 mg/kg] and ketamine [50 mg/kg] i.p.) by
using a common carotid artery catheter and a BP-1 pressure monitor
(World Precision Instruments). In vivo echocardiography of mouse hearts
and aortas was performed with a 15-MHz linear array transducer
interfaced with a Sequoia C256 (Acuson) as previously described
(18). In accordance with the American Society of
Echocardiography recommendations (37), parameters were
measured by using the leading-edge technique. Two-dimension-guided, M-mode echocardiograms were captured from long- and short-axis views of
an aorta to obtain the diameter (d). From the diameter, the
cross-sectional area (CSA) of the aorta was calculated as follows:
CSA =
× (d/2)2. Using
pulse wave doppler analysis, we determined the velocity-time integral
(VTI) . The stroke volume (SV) was then calculated with the following
equation: SV = CSA × VTI. The heart rate (HR) was directly
measured from the M-mode tracings of the aorta. The cardiac output (CO)
was then calculated with the following equation: CO = HR × SV. All echocardiogram evaluations were performed for at least 10 cardiac cycles per mouse and in a blind fashion by one observer.
Statistical analysis.
Analysis of variance with the Statview
program (SAS Institute) was performed to statistically compare all
measurements with a P value cutoff of 0.05. Means and
standard deviations are reported below.
 |
RESULTS |
On day 4 of P. berghei infection, mice appear to be
healthy and to have no obvious signs of disease. Virtually all C57BL/6 mice successfully infected (by i.p. or intravenous injection of 106 P. berghei-parasitized
erythrocytes) develop signs and symptoms of cerebral malaria on day 6 (rarely day 7) of infection; the mice become lethargic, lose their
righting and gripping reflexes, and die hours later. The majority of
the mice on day 6 of P. berghei infection have cracks in
their skulls, suggesting that severe brain swelling occurs. On average,
about one mouse per experiment is excluded because of inadequate
parasitemia. Most investigators believe that inadequate infection of
mice is due to injection of the parasite inoculum into an area outside
the peritoneal cavity, such as the bladder. Inadequately infected mice
are mice with levels of parasitemia of <0.5% on day 4 of infection
and are excluded from analysis; these mice generally succumb on day 8 or 9 of infection. Mice fail to gain weight during the infection and
exhibit significant (P < 0.05) weight loss by day 6 of infection.
The P. berghei model is therefore highly reproducible.
However, there are subtle differences in disease presentation from experiment to experiment. In all cases, we observed significant damage
in both brains and lungs, but in some experiments damage appeared to be
greater in the lungs than in the brains, whereas in other experiments
the converse was true.
Clinical and pathological signs of circulatory shock occur during
P. berghei infection.
To verify that the observed
increase in vascular permeability led to tissue edema (which also
occurs during septic shock), we determined the ratios of wet weight to
dry weight for selected organs during P. berghei infection
and evaluated other parameters, such as histology and whether the skull
was intact. Brains, lungs, and kidneys, but not hearts and intestines,
contained significantly (P < 0.05) greater amounts of
fluid on day 6 in P. berghei-infected mice than in
uninfected controls (Fig. 1). The P values
were 0.001, 0.0001, and 0.04 for brains, lungs, and kidneys,
respectively, and 0.95 and 0.49 for hearts and intestines,
respectively. About 50% of the mice on day 6 of P. berghei
infection had cracked skulls, and the extents of the cracks were
related to the degrees of brain edema and neurological complications
(loss of righting and gripping reflexes). Microscopic evaluation of
hematoxylin- and eosin-stained sections of lungs obtained from P. berghei-infected mice on day 6 of infection revealed marked
infiltration of mononuclear cells and granulocytes into alveolar space
and walls and thickening of alveolar walls. Severe hemorrhaging and
moderate congestion were observed in lungs of infected animals. In
addition, there were modest amounts of pink-stained alveolar spaces,
which is characteristic of lung edema.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Tissue edema during P. berghei malaria.
The ratios of wet weight to dry weight for selected tissues were
determined at zero time and on days 4 and 6 of infection for groups of
five mice. The ratios for days 4 and 6 were divided by ratios for zero
time. An asterisk indicates statistical significance
(P < 0.05) for a comparison of a group of infected
mice and uninfected controls.
|
|
To determine whether P. berghei-infected mice develop
acidosis, a clinical sign of circulatory shock, we assessed serum
lactate contents and pH values for groups of C57BL/6 mice during
P. berghei infection. The levels of serum lactate in
infected mice were significantly (P < 0.05) elevated
on day 4 of infection compared with the levels in uninfected controls,
and the levels increased even more by day 6 (P = 0.04 and P < 0.0001, respectively) (Fig.
2A). The levels of serum lactate in mice on day 6 of
infection were about five times higher than the levels in uninfected
controls. The pH of serum declined markedly during P. berghei malaria, and mice were acidotic (pH < 7.3) on days 4 and 6 of infection (P = 0.03 and P < 0.0001, respectively) (Fig. 2B). The levels of serum
HCO3
, which buffers the blood
at pH 7.4, declined significantly (P < 0.0001) by day
6 of infection compared with the levels in uninfected controls (Fig.
2C).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 2.
Acidosis of blood during P. berghei
malaria. Serum lactate (A), HCO3 (C), and
glutamate (D) levels were measured for groups of five mice at zero time
and on days 4 and 6 of P. berghei malaria. The blood pH
(B) was measured in a separate set of experimental animals. Similar
results were obtained in duplicate experiments. In addition, the
results for controls used in the experiments whose results are shown in
Fig. 5 were similar. An asterisk indicates statistical significance
(P < 0.05) for a comparison of a group of infected
mice and uninfected controls.
|
|
To determine whether glutamate levels in serum were high and possibly
inhibited production of HCO3
by the kidneys, we determined the levels of selected amino acids during
P. berghei malaria. Significantly elevated levels of
glutamate were detected in plasma on days 4 and 6 of infection compared with the levels in uninfected controls (P = 0.008 and
P = 0.0006, respectively) (Fig. 2D). No
significant changes in the serum levels of glycine, aspartate, and
alanine were detected during P. berghei malaria. However,
the levels of glutamate and aspartate in the erythrocytes were
significantly (P < 0.05) higher during P. berghei malaria; the glutamate concentrations at zero time and on
days 4 and 6 were 97 ± 20, 256 ± 46, and 239 ± 57 mM,
respectively, and the aspartate concentrations at these times were
79 ± 17, 201 ± 65, and 238 ± 3 mM, respectively.
These findings suggested that there was active transport into the
infected erythrocytes.
To investigate whether increased vascular permeability and tissue edema
caused the blood pressure to fall during P. berghei malaria
(which also occurs during septic shock), we measured the blood pressure
of infected C57BL/6 mice. The mean arterial blood pressure decreased
significantly (P < 0.05) on day 4 of P. berghei infection compared with the mean arterial blood pressure
of uninfected controls and fell further by day 6 (Fig.
3).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Mean arterial blood pressure during P.
berghei malaria. Mean arterial blood pressure was measured for
groups of five mice at zero time and on days 4 and 6 of P.
berghei malaria. Similar results were obtained a duplicate
experiment. An asterisk indicates statistical significance
(P < 0.05) for a comparison of a group of infected
mice and uninfected controls.
|
|
Clinical symptoms of circulatory shock during P.
berghei malaria are markedly reduced after depletion of
CD8+ T cells.
CD8-depleted mice did not exhibit any
neurological signs of cerebral malaria (such as loss of the righting
reflex or the ability to grip) and were not lethargic, whereas rat
IgG-treated controls showed neurological signs of cerebral malaria and
were lethargic. The CD8-depleted mice were adequately
infected because the parasitemia in anti-CD8
mAb-treated mice was similar than that in rat IgG-treated controls. Therefore, the two groups of mice had similar clinical symptoms of uncomplicated malaria (i.e., fever and anemia). In each of
the experiments with CD8-depleted mice, we determined the
percentage of CD3+ CD8+ T
cells in the peripheral blood by flow cytometry on day 4 of infection
and performed an experimental analysis on day 6. Few, if any,
CD3+ CD8+ cells (0.0 ± 0.0%) were detected by flow cytometry in the anti-CD8 mAb-treated
mice, whereas more than 8% of the peripheral blood leukocytes in rat
IgG-treated mice were labeled with anti-CD3 and anti-CD8 mAbs. The
percentages of CD8+ T cells in peripheral blood
were similar for infected rat IgG-treated mice and uninfected controls.
To determine whether CD8+ T cells in the tissues
actually contribute to the increased vascular permeability during
experimental malaria, we measured vascular permeability by the Evans
Blue dye leakage technique on day 6 of P. berghei infection
of CD8-depleted mice. There was a marked, significant
(P < 0.05) reduction in vascular permeability in the
brains, lungs, kidneys, and hearts of anti-CD8 mAb-treated mice with
P. berghei malaria compared with the vascular permeability
in infected rat IgG-treated controls (Fig. 4A). The
P values were 0.0001, <0.0001, 0.002, and 0.0009 for the
brains, lungs, hearts, and kidneys, respectively. There was marked
tissue edema in lungs and brains of rat IgG-treated controls on day 6 of P. berghei infection (Fig. 4B). However, CD8 depletion
significantly (P < 0.05) protected against edema in
brains, lungs, and kidneys during P. berghei malaria
compared with the results obtained for rat IgG-treated and infected
controls; the P values were <0.0001 and 0.01 for brains and
lungs, respectively, and 0.07, 0.8, and 0.6 for kidneys, hearts, and
intestines, respectively. None of the anti-CD8 mAb-treated mice
infected with P. berghei showed signs of cracked skulls,
whereas two of five infected rat IgG-treated mice had cracked skulls.
In some experiments vascular permeability appeared to predominate in
lungs, whereas in other experiments changes in brains predominated
(Fig. 1 and 4).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Ratios of vascular permeability (A) and tissue edema (B)
in CD8+ T-cell-depleted mice (anti-CD8) infected with
P. berghei malaria to vascular permeability and tissue
edema in uninfected controls (uninf). These ratios are compared with
the ratios of vascular permeability (A) and tissue edema (B) in rat
IgG-treated and infected mice (rat IgG) to vascular permeability and
tissue edema in uninfected controls. Vascular permeability was
determined by the Evans Blue technique for selected tissues from groups
of eight mice. The ratios of wet weight to dry weight for selected
tissues were determined on day 6 of infection for groups of five mice.
The vascular permeability or ratio of wet weight to dry weight for
infected groups of animals (anti-CD8 mAb and rat IgG mAb treated) were
divided by values for uninfected animals. Similar results were obtained
in replicate experiments for vascular permeability and in duplicate
experiments for tissue edema. An asterisk indicates statistical
significance (P < 0.05) for a comparison of a
group of infected CD8-depleted mice and infected rat IgG-treated
controls.
|
|
To determine whether CD8+ T cells actually
contribute to pathogenesis of circulatory shock during experimental
malaria, we assessed acidosis in P. berghei-infected mice
depleted of CD8+ T cells by mAb treatment. The
serum lactate, HCO3
, and
glutamate contents of infected CD8-depleted mice were
significantly (P < 0.05) decreased compared with
the contents of infected rat IgG-injected controls (Fig.
5A, C, and D); the P values were 0.005, 0.0002, and 0.01 for lactate,
HCO3
, and glutamate levels,
respectively. The blood pH (Fig. 5B) was significantly
(P = 0.01) higher in CD8-depleted mice infected with
P. berghei than in infected rat IgG-treated controls.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 5.
Acidosis of blood in CD8+ T-cell-depleted
mice infected with P. berghei malaria. Serum lactate
(A), HCO3 (C), and glutamate (D) levels were
measured in groups of four mice at zero time and on day 6 of P.
berghei malaria. The groups of infected mice were treated with
either anti-CD8 mAb or control rat IgG. The blood pH (B) was measured
with a separate set of experimental animals. Two of five mice in the
control rat IgG-injected group died on day 6 of infection before blood
was obtained for pH measurement, so the pH values are averages based on
the data for three mice. Similar results were obtained in a duplicate
experiment. An asterisk indicates statistical significance
(P < 0.05) for a comparison of a group of infected
mice and uninfected controls.
|
|
To determine whether the observed changes in mean arterial blood
pressure were also dependent on CD8+ T cells, we
assessed blood pressure on day 6 of infection in C57BL/6 mice depleted
of CD8+ T cells by mAb treatment. CD8-depleted
mice infected with P. berghei had a mean arterial blood
pressure similar to that of infected rat IgG-treated mice, and both of
the values were lower than the value obtained for the uninfected
controls (Fig. 6). However, cardiac output was
significantly (P < 0.05) lower in infected rat
IgG-treated mice than in either infected anti-CD8 mAb-treated mice
(P = 0.02) or uninfected controls (P = 0.0005). Cardiac output was slightly lower in infected CD8-depleted
mice than in uninfected mice, but the difference was not statistically significant.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Cardiac output (A) and mean arterial blood pressure (B)
in CD8+ T-cell-depleted mice infected with P.
berghei. The mean arterial blood pressure was measured for
groups of five mice at zero time and on day 6 of P.
berghei malaria. The groups of infected mice were treated with
either anti-CD8 mAb or control rat IgG. This experiment was performed
once. An asterisk indicates statistical significance
(P < 0.05) for a comparison of a group of infected
mice and uninfected controls.
|
|
 |
DISCUSSION |
Our studies were designed to examine the hypothesis that
complications that occur during P. berghei malaria in mice
are consistent with circulatory shock. Unlike most studies of P. berghei malaria, which focus exclusively on changes in the brain,
in our study we examined tissues that are damaged in humans with
P. falciparum malaria to develop a complete picture of
malarial pathogenesis. Our observation that vascular leakage occurs in
the brains of mice with P. berghei malaria prior to the
onset of symptoms confirms the results of similar studies (5,
40). The finding that breakdown of the blood-brain barrier
occurs prior to the onset of symptoms is important because it shows
that vascular leakage occurs not merely because an animal is moribund
and tissue integrity is failing. Rather, the breakdown of the
blood-brain barrier may contribute to the animal's demise. Increased
vascular leakage was also observed in lungs, hearts, and kidneys. This
result confirmed our previous findings obtained by using Evans Blue dye
leakage and a radiolabeled mAb technique (41). It also
agrees in large part with the results of semiquantitative Monastral
Blue studies in which increased vascular permeability was observed in
lungs, brains, hearts, and kidneys (33); however, Neill
and Hunt also observed increased permeability in the liver and spleen,
which are blood filtration organs with little, if any, permeability barrier. Endothelial cells actively transport Monastral Blue across the
endothelium, and there is no relationship between hemorrhage and
extrusion of Monastral Blue into tissue, suggesting that Monastral Blue
extrusion does not always reflect vascular leakage. Collectively, the
results indicate that vascular permeability increases markedly during
P. berghei malaria in several organs besides the brain.
One consequence of increased vascular permeability is tissue edema. An
increase in the ratio of wet weight to dry weight is a well-recognized
indication of tissue edema. We observed significant (P < 0.05) increases in the ratios of wet weight to dry weight in the
lungs and brains of P. berghei-infected mice compared with the ratios for uninfected controls; this finding indicates that tissue
edema occurs during experimental malaria. Even in our genetically controlled (both parasite and mouse) model of malaria, we observed striking increases in brain permeability in some experiments (Fig. 1),
striking increases in lung permeability in other experiments (Fig. 4),
and equal increases in brain permeability and in lung permeability in
still other experiments. This reflects the situation in humans; some
patients with P. falciparum develop mainly cerebral malaria,
other patients develop respiratory distress, and most patients develop
a combination of cerebral malaria and respiratory distress
(29).
Increased vascular permeability and tissue edema contribute to poor
tissue perfusion, resulting in buildup of waste products in the blood.
The increased lung vascular permeability and lung edema interfere with
gas exchange in P. berghei-infected mice compared with gas
exchange in uninfected controls. When tissue oxygenation is poor, a
switch to glycolysis occurs, and this results in lactic acid
production, tissue acidosis, and a drop in the extracellular pH. The
malarial parasite also uses glycolysis, and its production of lactic
acid may exacerbate the acidosis. Indeed, the lactic acid concentration
in serum increases markedly during P. berghei malaria
compared with the serum lactic acid concentration in uninfected
controls. Acidosis (pH < 7.3), which occurs on day 4 of P. berghei infection, when the animals appear healthy, is usually
prevented by increasing the amount of serum HCO3
. Our data indicate that
malaria results in increased serum glutamate levels. The levels of
glutamate observed during malaria should inhibit
HCO3
production by the kidneys
(4), resulting in the observed decline in serum
HCO3
levels on day 6 of
infection. The high levels of glutamate may also contribute to
neurological complications of malaria because glutamate has profound
effects on the central nervous system. Collectively, the changes
indicate that significant (P < 0.05) metabolic
derangements occur with experimental malaria, possibly as a result of
initial changes in vascular permeability.
The complications of shock observed in P. berghei-infected
mice are similar to those of septic shock. In both diseases, there is
multiple organ failure (particularly lung, brain, kidney, and heart
failure) and respiratory distress with lactic acidosis. Our data
showing (i) increased vascular leakage and edema in the lungs and (ii)
histological changes with infiltrating cells, alveolar wall
thickening, congestion, and fluid in alveolar space support the
contention that respiratory distress occurs during P. berghei malaria in mice. This respiratory distress exacerbates
metabolic complications and contributes to the vicious cycle during
malarial pathogenesis and septic shock. As in septic shock, hemodynamic changes also occur during P. berghei malaria. The observed
decreases in mean arterial blood pressure and cardiac output on day 6 of P. berghei infection probably exacerbate the metabolic
complications, thereby creating positive feedback and leading
ultimately to death of the animal. These findings collectively indicate
that mice infected with P. berghei are in circulatory shock,
which resembles septic shock.
There are reports of shock occurring in patients with severe P. falciparum malaria, and the World Health Organization lists shock
as a poor prognostic indicator for malaria (3, 23). There
are also numerous parallels between complications in patients with
severe malaria and complications in patients with septic shock,
including a prominent role of TNF in pathogenesis (21). While some workers report no breakdown in the blood-brain barrier in
humans with cerebral malaria (2, 26), other workers have observed increased blood-brain permeability which was associated with
poor outcome (34, 35). In addition, retinal hemorrhages are poor prognostic factors and are believed to reflect petechial hemorrhaging into the brain (5, 25). Lactic acidosis and shock are other poor prognostic factors for severe P. falciparum malaria (22). Thus, we propose that
circulatory shock mediates damage in the brains and lungs of some
patients with severe P. falciparum malaria. Consequently,
P. berghei infection of mice is a model for severe P. falciparum malaria and should allow researchers to study malarial shock.
The concept that malarial pathogenesis is circulatory shock actually
unifies the mechanical hypothesis and the inflammatory hypothesis. For
example, minithrombi occur in the late stages of septic shock. These
minithrombi may be analogous to erythrocyte rosetting during P. falciparum malaria and congestion in cerebral blood vessels. The
immune response directed at the parasite may cause the vascular leakage
and edema that are observed and contribute to the circulatory
complications of malaria, which is the basis for the inflammatory hypothesis.
To test whether the immune response contributes to the circulatory
complications of malaria, we assessed these complications in CD8
T-cell-depleted mice. We selected CD8+ T
lymphocytes because this T-cell subset is required for death due to
experimental cerebral malaria (16, 44). Mice depleted of
CD8+ T cells by mAb during P. berghei
malaria exhibit (i) attenuated vascular permeability and edema in their
lungs and brains, (ii) diminished lactic acidosis, and (iii) no
increase in serum glutamate levels compared with the levels in rat
IgG-treated and infected controls. CD8-depleted mice infected with
P. berghei also exhibit significantly (P < 0.05) lower cardiac output than rat IgG-treated and infected controls.
Collectively, these findings indicate that CD8-depleted mice exhibit
markedly ameliorated circulatory shock compared with the circulatory
shock of rat IgG-treated controls. The pathogenic mechanism(s)
mediating cerebral malaria and respiratory distress may in fact be
similar because depletion of CD8+ T cells
protects against vascular permeability changes and edema in both brains
and lungs.
The reemergence of P. falciparum, which causes severe
malaria, and the development of drug resistance by the parasite
highlight the need to develop new ways of treating malaria. To develop
new treatments for patients with severe malaria, we need to better understand its pathogenesis. Our observations indicate that P. berghei-infected mice develop circulatory shock, which may be the
underlying mechanism for both cerebral malaria and respiratory distress
with acidosis. The immune system (specifically
CD8+ T cells) contributes to the development of
these complications. If our concept of circulatory shock underlying
malarial pathogenesis is validated after analysis of patients with
severe P. falciparum malaria, then novel treatment
modalities may be developed due to an improved understanding of
malarial pathogenesis. Thus, we predict that treatments for septic
shock should also be effective in blunting the severe complications of malaria.
 |
ACKNOWLEDGMENTS |
This research was supported by NIH grants KO8 AI01438(to W.-L.
Chang), RO1 HL60849 (to D. J. Lefer), PO1 DK43785 (to D. N. Granger and D. J. Lefer), and RO1 AI40667 (to H. C. van der Heyde).
We thank Philippe Bauer for his assistance with lactic acid and
bicarbonate measurements.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine, LSU Health Sciences Center-Shreveport, P.O. Box 33932, Shreveport, LA 71130. Phone: (318) 675-5990. Fax: (318) 675-5764. E-mail: wchang{at}lsumc.edu.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Aikawa, M.,
M. Iseki,
J. W. Barnwell,
D. Taylor,
M. M. Oo, and R. J. Howard.
1990.
The pathology of human cerebral malaria.
Am. J. Trop. Med. Hyg.
43:30-37.
|
| 2.
|
Brown, H. C.,
T. T. Chau,
N. T. Mai,
N. P. Day,
D. X. Sinh,
N. J. White,
T. T. Hien,
J. Farrar, and G. D. Turner.
2000.
Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam.
Neurology
55:104-111[Abstract/Free Full Text].
|
| 3.
|
Bruneel, F.,
B. Gachot,
J. F. Timsit,
M. Wolff,
J. P. Bedos,
B. Regnier, and F. Vachon.
1997.
Shock complicating severe falciparum malaria in European adults.
Intensive Care Med.
23:698-701[CrossRef][Medline].
|
| 4.
|
Carter, P., and T. Welbourne.
1997.
Glutamate transport regulation of renal glutaminase flux in vivo.
Am. J. Physiol
273:E521-E527[Abstract/Free Full Text].
|
| 5.
|
Chang-Ling, T.,
A. L. Neill, and N. H. Hunt.
1992.
Early microvascular changes in murine cerebral malaria detected in retinal whole mounts.
Am. J. Pathol.
140:1121-1130[Abstract].
|
| 6.
|
Clark, I. A.,
F. M. al Yaman, and L. S. Jacobson.
1997.
The biological basis of malarial disease.
Int. J. Parasitol.
27:1237-1249[CrossRef][Medline].
|
| 7.
|
de Kossodo, S., and G. E. Grau.
1993.
Role of cytokines and adhesion molecules in malaria immunopathology.
Stem Cells
11:41-48[Abstract].
|
| 8.
|
Eling, W. M., and P. G. Kremsner.
1994.
Cytokines in malaria, pathology and protection.
Biotherapy
7:211-221[CrossRef][Medline].
|
| 9.
|
Favre, N.,
C. Da Laperousaz,
B. Ryffel,
N. A. Weiss,
B. A. Imhof,
W. Rudin,
R. Lucas, and P. F. Piguet.
1999.
Role of ICAM-1 (CD54) in the development of murine cerebral malaria.
Microbes Infect.
1:961-968[CrossRef][Medline].
|
| 10.
|
Finley, R. W.,
L. J. Mackey, and P. H. Lambert.
1982.
Virulent P. berghei malaria: prolonged survival and decreased cerebral pathology in cell-dependent nude mice.
J. Immunol.
129:2213-2218[Abstract].
|
| 11.
|
Grau, G. E.,
P. F. Piguet,
H. D. Engers,
J. A. Louis,
P. Vassalli, and P. H. Lambert.
1986.
L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.
J. Immunol.
137:2348-2354[Abstract].
|
| 12.
|
Grau, G. E.,
P. F. Piguet,
P. Vassalli, and P. H. Lambert.
1989.
Involvement of tumour necrosis factor and other cytokines in immune-mediated vascular pathology.
Int. Arch. Allergy Appl. Immunol.
88:34-39[Medline].
|
| 13.
|
Grau, G. E.,
P. Pointaire,
P. F. Piguet,
C. Vesin,
H. Rosen,
I. Stamenkovic,
F. Takei, and P. Vassalli.
1991.
Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria.
Eur. J. Immunol.
21:2265-2267[Medline].
|
| 14.
|
Guyton, A. C., and J. E. Hall.
1996.
Circulatory shock and physiology of its treatment, p. 285-293.
In
A. C. Guyton, and J. E. Hall (ed.), Textbook of medical physiology. W. B. Saunders Company, Philadelphia, Pa.
|
| 15.
|
Hearn, J.,
N. Rayment,
D. N. Landon,
D. R. Katz, and J. B. de Souza.
2000.
Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature.
Infect. Immun.
68:5364-5376[Abstract/Free Full Text].
|
| 16.
|
Hermsen, C.,
T. van de Wiel,
E. Mommers,
R. Sauerwein, and W. Eling.
1997.
Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease.
Parasitology
114:7-12.
|
| 17.
|
Hoffmann, E. J.,
W. P. Weidanz, and C. A. Long.
1984.
Susceptibility of CXB recombinant inbred mice to murine plasmodia.
Infect. Immun.
43:981-985[Abstract/Free Full Text].
|
| 18.
|
Hoffmeyer, M. R.,
S. P. Jones,
C. R. Ross,
B. Sharp,
M. B. Grisham,
F. S. Laroux,
T. J. Stalker,
R. Scalia, and D. J. Lefer.
2000.
Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice.
Circ. Res.
87:812-817[Abstract/Free Full Text].
|
| 19.
|
Kaul, D. K.,
X. D. Liu,
R. L. Nagel, and H. L. Shear.
1998.
Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria.
Am. J. Trop. Med. Hyg.
58:240-247[Abstract].
|
| 20.
|
Kaul, D. K.,
R. L. Nagel,
J. F. Llena, and H. L. Shear.
1994.
Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates.
Am. J. Trop. Med. Hyg.
50:512-521.
|
| 21.
|
Knight, J. C.,
I. Udalova,
A. V. Hill,
B. M. Greenwood,
N. Peshu,
K. Marsh, and D. Kwiatkowski.
1999.
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria.
Nat. Genet.
22:145-150[CrossRef][Medline].
|
| 22.
|
Krishna, S.,
D. W. Waller,
F. ter Kuile,
D. Kwiatkowski,
J. Crawley,
C. F. Craddock,
F. Nosten,
D. Chapman,
D. Brewster, and P. A. Holloway.
1994.
Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance.
Trans. R. Soc. Trop. Med. Hyg.
88:67-73[CrossRef][Medline].
|
| 23.
|
Lagudis, S.,
L. F. Camargo,
E. C. Meyer,
C. J. Fernandes,
N. Akamine, and E. Knobel.
2000.
Hyperdynamic shock in falciparum malaria.
Intensive Care Med.
26:142[CrossRef][Medline].
|
| 24.
|
Ledbetter, J. A.,
R. V. Rouse,
H. S. Micklem, and L. A. Herzenberg.
1980.
T cell subsets defined by expression of Lyt-1:2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views.
J. Exp. Med.
152:280-295[Abstract/Free Full Text].
|
| 25.
|
Looareesuwan, S.,
D. A. Warrell,
N. J. White,
P. Chanthavanich,
M. J. Warrell,
S. Chantaratherakitti,
S. Changswek,
L. Chongmankongcheep, and C. Kanchanaranya.
1983.
Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria.
Am. J. Trop. Med. Hyg.
32:911-915.
|
| 26.
|
Looareesuwan, S.,
D. A. Warrell,
N. J. White,
P. Sutharasamai,
P. Chanthavanich,
K. Sundaravej,
B. E. Juel-Jensen,
D. Bunnag, and T. Harinasuta.
1983.
Do patients with cerebral malaria have cerebral oedema? A computed tomography study.
Lancet
i:434-437[CrossRef].
|
| 27.
|
Lucas, R.,
J. N. Lou,
P. Juillard,
M. Moore,
H. Bluethmann, and G. E. Grau.
1997.
Respective role of TNF receptors in the development of experimental cerebral malaria.
J. Neuroimmunol.
72:143-148[CrossRef][Medline].
|
| 28.
|
Mackey, L. J.,
A. Hochmann,
C. H. June,
C. E. Contreras, and P. H. Lambert.
1980.
Immunopathological aspects of Plasmodium berghei infection in five strains of mice. II. Immunopathology of cerebral and other tissue lesions during the infection.
Clin. Exp. Immunol.
42:412-420[Medline].
|
| 29.
|
Marsh, K.,
D. Forster,
C. Waruiru,
I. Mwangi,
M. Winstanley,
V. Marsh,
C. Newton,
P. Winstanley,
P. Warn, and N. Peshu.
1995.
Indicators of life-threatening malaria in African children.
N. Engl. J. Med.
332:1399-1404[Abstract/Free Full Text].
|
| 30.
|
McGuire, W.,
A. V. Hill,
C. E. Allsopp,
B. M. Greenwood, and D. Kwiatkowski.
1994.
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.
Nature
371:508-510[CrossRef][Medline].
|
| 31.
|
Miller, L. H.,
M. F. Good, and G. Milon.
1994.
Malaria pathogenesis.
Science
264:1878-1883[Abstract/Free Full Text].
|
| 32.
|
Natelson, S.
1951.
Routine use of ultramicro methods in the clinical laboratory.
Am. J. Pathol.
21:1153-1158.
|
| 33.
|
Neill, A. L., and N. H. Hunt.
1992.
Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice.
Parasitology
105:165-175.
|
| 34.
|
Newton, C. R.,
J. Crawley,
A. Sowumni,
C. Waruiru,
I. Mwangi,
M. English,
S. Murphy,
P. A. Winstanley,
K. Marsh, and F. J. Kirkham.
1997.
Intracranial hypertension in Africans with cerebral malaria.
Arch. Dis. Child.
76:219-226[Abstract/Free Full Text].
|
| 35.
|
Newton, C. R.,
N. Peshu,
B. Kendall,
F. J. Kirkham,
A. Sowunmi,
C. Waruiru,
I. Mwangi,
S. A. Murphy, and K. Marsh.
1994.
Brain swelling and ischaemia in Kenyans with cerebral malaria.
Arch. Dis. Child.
70:281-287[Abstract].
|
| 36.
|
Rest, J. R.
1982.
Cerebral malaria in inbred mice. I. A new model and its pathology.
Trans. R. Soc. Trop. Med. Hyg.
76:410-415[CrossRef][Medline].
|
| 37.
|
Schiller, N. B.,
P. M. Shah,
M. Crawford,
A. DeMaria,
R. Devereux,
H. Feigenbaum,
H. Gutgesell,
N. Reichek,
D. Sahn, and I. Schnittger.
1989.
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.
J. Am. Soc. Echocardiogr.
2:358-367[Medline].
|
| 38.
|
Shear, H. L.,
M. W. Marino,
C. Wanidworanun,
J. W. Berman, and R. L. Nagel.
1998.
Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria.
Am. J. Trop. Med. Hyg.
59:852-858[Abstract].
|
| 39.
|
Tateishi, H.,
K. Mitsuyama,
A. Toyonaga,
M. Tomoyose, and K. Tanikawa.
1997.
Role of cytokines in experimental colitis: relation to intestinal permeability.
Digestion
58:271-281[Medline].
|
| 40.
|
Thumwood, C. M.,
N. H. Hunt,
I. A. Clark, and W. B. Cowden.
1988.
Breakdown of the blood-brain barrier in murine cerebral malaria.
Parasitology
96:579-589.
|
| 41.
|
van der Heyde, H. C.,
P. Bauer,
G. Sun,
W. L. Chang,
L. Yin,
J. W. Fuseler, and D. N. Granger.
2001.
Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.
Infect. Immun.
69:3460-3465[Abstract/Free Full Text].
|
| 42.
|
van der Heyde, H. C.,
D. D. Manning, and W. P. Weidanz.
1993.
Role of CD4+ T cells in the expansion of the CD4-, CD8- gamma delta T cell subset in the spleens of mice during blood-stage malaria.
J. Immunol.
151:6311-6317[Abstract].
|
| 43.
|
von Andrian, U. H., and C. R. Mackay.
2000.
T-cell function and migration. Two sides of the same coin.
N. Engl. J. Med.
343:1020-1034[Free Full Text].
|
| 44.
|
Yanez, D. M.,
D. D. Manning,
A. J. Cooley,
W. P. Weidanz, and H. C. van der Heyde.
1996.
Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
J. Immunol.
157:1620-1624[Abstract].
|
| 45.
|
Young, L. S.
2000.
Sepsis syndrome, p. 806-820.
In
G. L. Mandel, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, Pa.
|
Infection and Immunity, December 2001, p. 7341-7348, Vol. 69, No. 12
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7341-7348.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Miu, J., Mitchell, A. J., Muller, M., Carter, S. L., Manders, P. M., McQuillan, J. A., Saunders, B. M., Ball, H. J., Lu, B., Campbell, I. L., Hunt, N. H.
(2008). Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency. J. Immunol.
180: 1217-1230
[Abstract]
[Full Text]
-
Gramaglia, I., Sahlin, H., Nolan, J. P., Frangos, J. A., Intaglietta, M., van der Heyde, H. C.
(2005). Cell- Rather Than Antibody-Mediated Immunity Leads to the Development of Profound Thrombocytopenia during Experimental Plasmodium berghei Malaria. J. Immunol.
175: 7699-7707
[Abstract]
[Full Text]
-
Schaecher, K., Kumar, S., Yadava, A., Vahey, M., Ockenhouse, C. F.
(2005). Genome-Wide Expression Profiling in Malaria Infection Reveals Transcriptional Changes Associated with Lethal and Nonlethal Outcomes. Infect. Immun.
73: 6091-6100
[Abstract]
[Full Text]
-
Hansen, D. S., Evans, K. J., D'Ombrain, M. C., Bernard, N. J., Sexton, A. C., Buckingham, L., Scalzo, A. A., Schofield, L.
(2005). The Natural Killer Complex Regulates Severe Malarial Pathogenesis and Influences Acquired Immune Responses to Plasmodium berghei ANKA. Infect. Immun.
73: 2288-2297
[Abstract]
[Full Text]
-
van der Heyde, H. C., Gramaglia, I., Sun, G., Woods, C.
(2005). Platelet depletion by anti-CD41 ({alpha}IIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines. Blood
105: 1956-1963
[Abstract]
[Full Text]
-
Bagot, S., Nogueira, F., Collette, A., do Rosario, V., Lemonier, F., Cazenave, P.-A., Pied, S.
(2004). Comparative Study of Brain CD8+ T Cells Induced by Sporozoites and Those Induced by Blood-Stage Plasmodium berghei ANKA Involved in the Development of Cerebral Malaria. Infect. Immun.
72: 2817-2826
[Abstract]
[Full Text]
-
Tao, W., Sherwood, E. R.
(2004). {beta}2-Microglobulin knockout mice treated with anti-asialoGM1 exhibit improved hemodynamics and cardiac contractile function during acute intra-abdominal sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol.
286: R569-R575
[Abstract]
[Full Text]
-
Sherwood, E. R., Lin, C. Y., Tao, W., Hartmann, C. A., Dujon, J. E., French, A. J., Varma, T. K.
(2003). {beta}2 Microglobulin Knockout Mice Are Resistant to Lethal Intraabdominal Sepsis. Am. J. Respir. Crit. Care Med.
167: 1641-1649
[Abstract]
[Full Text]
-
Belnoue, E., Kayibanda, M., Deschemin, J.-C., Viguier, M., Mack, M., Kuziel, W. A., Renia, L.
(2003). CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood
101: 4253-4259
[Abstract]
[Full Text]
-
Chang, W.-L., Li, J., Sun, G., Chen, H.-L., Specian, R. D., Berney, S. M., Granger, D. N., van der Heyde, H. C.
(2003). P-Selectin Contributes to Severe Experimental Malaria but Is Not Required for Leukocyte Adhesion to Brain Microvasculature. Infect. Immun.
71: 1911-1918
[Abstract]
[Full Text]
-
Belnoue, E., Kayibanda, M., Vigario, A. M., Deschemin, J.-C., Rooijen, N. v., Viguier, M., Snounou, G., Renia, L.
(2002). On the Pathogenic Role of Brain-Sequestered {alpha}{beta} CD8+ T Cells in Experimental Cerebral Malaria. J. Immunol.
169: 6369-6375
[Abstract]
[Full Text]